NCT07066046

Brief Summary

The study aims to evaluate the effectiveness of artificial intelligence-assisted colonoscopy in increasing adenoma detection rate and the accuracy in the characterization of colorectal lesions, compared to standard colonoscopy, in a randomized controlled clinical trial setting.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
1,000

participants targeted

Target at P75+ for not_applicable

Timeline
7mo left

Started Feb 2025

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress69%
Feb 2025Dec 2026

Study Start

First participant enrolled

February 1, 2025

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

May 22, 2025

Completed
2 months until next milestone

First Posted

Study publicly available on registry

July 15, 2025

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2026

Completed
10 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2026

Expected
Last Updated

July 16, 2025

Status Verified

July 1, 2025

Enrollment Period

1 year

First QC Date

May 22, 2025

Last Update Submit

July 15, 2025

Conditions

Keywords

AdenomaArtificial IntelligenceColonoscopyColorectal lesions

Outcome Measures

Primary Outcomes (1)

  • Number of patients with at least one adenoma detected, confirmed by histopathological analysis, during colonoscopy, in the AI group vs. control group

    The measure will be expressed as the number and percentage (%) of patients with at least one adenoma detected during colonoscopy and confirmed by histopathological analysis, comparing the AI and non-AI groups (CAD EYE). Detection will be based on the analysis of biopsies performed and processed according to the standard protocol.

    7 days after colonoscopy (estimated time for histopathological report release).

Secondary Outcomes (1)

  • Diagnostic accuracy of CAD EYE for characterization of lesions as neoplastic (adenoma) or non-neoplastic (hyperplastic), compared to histopathological analysis as the gold standard.

    7 days after colonoscopy

Study Arms (2)

Colonoscopy with the aid of artificial intelligence

ACTIVE COMPARATOR

Stratum 1: Patients aged 18 to 44 years Stratum 2: Patients aged 45 to 75 years Stratum 3: Patients aged 76 years or older

Procedure: Colonoscopy

Colonoscopy without the aid of artificial intelligence

ACTIVE COMPARATOR

Stratum 1: Patients aged 18 to 44 years Stratum 2: Patients aged 45 to 75 years Stratum 3: Patients aged 76 years or older

Procedure: Colonoscopy

Interventions

ColonoscopyPROCEDURE

This single-center, randomized, open-label clinical trial will assess the effectiveness of artificial intelligence (AI)-assisted colonoscopy versus standard high-definition colonoscopy in detecting and characterizing colorectal lesions. Conducted over 12 months in São Paulo, Brazil, the study will include 100 adult patients undergoing elective colonoscopy. Participants will be stratified by age and randomized (1:1) after sedation. All lesions will be resected, recorded, and analyzed histologically. The intervention group will also include AI output data (CAD EYE). The primary goals are to evaluate adenoma detection rate (ADR) and AI diagnostic accuracy. Given the global burden of colorectal cancer (CRC), particularly in developing countries, this study aims to provide real-world data on the impact of AI in CRC screening.

Colonoscopy with the aid of artificial intelligenceColonoscopy without the aid of artificial intelligence

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • All patients aged 18 years or older, with an elective indication for colonoscopy who sign the informed consent form agreeing to participate in the study.

You may not qualify if:

  • History of inflammatory bowel disease.
  • History of colorectal cancer.
  • Personal history of colorectal surgery.
  • Contraindication to endoscopic biopsies.
  • History of intestinal polyposis syndromes.
  • Urgent or emergency cases.
  • Presence of severe, decompensated comorbidities, or with a score of 3 or higher according to the American Society of Anesthesiologists (ASA) classification.
  • Incomplete colonoscopy that does not reach the cecum.
  • Insufficient or inadequate bowel preparation, with a score lower than 6 on the Boston Bowel Preparation Scale.
  • Patients who do not agree to participate in the study and do not sign the informed consent form (ICF).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hospital das Clínicas da Faculdade de Medicina da USP

São Paulo, São Paulo, 05403-010, Brazil

RECRUITING

Related Links

MeSH Terms

Conditions

Colorectal NeoplasmsAdenomatous Polyposis ColiAdenoma

Interventions

Colonoscopy

Condition Hierarchy (Ancestors)

Intestinal NeoplasmsGastrointestinal NeoplasmsDigestive System NeoplasmsNeoplasms by SiteNeoplasmsDigestive System DiseasesGastrointestinal DiseasesColonic DiseasesIntestinal DiseasesRectal DiseasesAdenomatous PolypsNeoplasms, Glandular and EpithelialNeoplasms by Histologic TypeNeoplastic Syndromes, HereditaryIntestinal PolyposisGenetic Diseases, InbornCongenital, Hereditary, and Neonatal Diseases and Abnormalities

Intervention Hierarchy (Ancestors)

Endoscopy, GastrointestinalEndoscopy, Digestive SystemDiagnostic Techniques, Digestive SystemDiagnostic Techniques and ProceduresDiagnosisEndoscopyDiagnostic Techniques, SurgicalDigestive System Surgical ProceduresSurgical Procedures, OperativeMinimally Invasive Surgical Procedures

Central Study Contacts

Márcio Roberto Facanali Júnior

CONTACT

Adriana Vaz Safatle Ribeiro, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
INVESTIGATOR
Purpose
DIAGNOSTIC
Intervention Model
PARALLEL
Model Details: A controlled, open-label, prospective, randomized clinical study is proposed, to be conducted at a single center in a Brazilian referral hospital for colorectal cancer located in São Paulo, São Paulo. Over a period of 12 consecutive months, patients who agree to participate in the study will undergo a colonoscopy. All patients aged 18 years or older, with an elective indication for colonoscopy, who sign the informed consent form agreeing to participate in the study, will be included.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistente - Endoscopia ICESP

Study Record Dates

First Submitted

May 22, 2025

First Posted

July 15, 2025

Study Start

February 1, 2025

Primary Completion

February 1, 2026

Study Completion (Estimated)

December 1, 2026

Last Updated

July 16, 2025

Record last verified: 2025-07

Data Sharing

IPD Sharing
Will not share

We do not plan to share Individual Participant Data (IPD) with other researchers due to privacy concerns and the nature of the study

Locations